Document Detail


Prophylaxis of postoperative nausea and vomiting in patients scheduled for breast surgery.
MedLine Citation:
PMID:  17163275     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Breast surgery performed under general anaesthesia is associated with a high incidence of postoperative nausea and vomiting (PONV). Between 60% and 80% of patients undergoing mastectomy (with axillary dissection) experience PONV. Pharmacological approaches have been investigated to reduce PONV after breast surgery. Traditional antiemetics (droperidol and metoclopramide) are frequently used for the prevention of PONV during the first 24 hours after anaesthesia. The available non-traditional antiemetics that have been shown to be effective for prophylaxis against PONV are dexamethasone, clonidine, propofol and supplemental oxygen. Antiserotonins (ondansetron, granisetron, tropisetron, dolasetron and ramosetron) are highly effective for preventing PONV for 24 hours postoperatively, compared with traditional antiemetics. Ramosetron is effective for the long-term (up to 48 hours) prevention of PONV. Better results can be obtained by combining antiemetics, because they have different sites of action. Combination antiemetic therapy is often effective for preventing PONV after breast surgery. Combinations of an antiserotonin (granisetron or dolasetron) and droperidol or dexamethasone are more effective than monotherapy with antiserotonins. A non-pharmacological technique is acupuncture at the P6 (Nei-Kuan) point. Overall, these pharmacological and non-pharmacological approaches reduce the incidence of PONV following breast surgery. Most of the published trials indicate improved prophylaxis of PONV following breast surgery by avoiding risk factors, and by using effective antiemetic agents in women scheduled for mastectomy (with axillary dissection). The clinician must weigh the benefits of using pharmacological and non-pharmacological approaches for PONV against the risk of occurrence of adverse events.
Authors:
Yoshitaka Fujii
Related Documents :
17387715 - Correlates of referral practices of general surgeons to plastic surgeons for mastectomy...
3044575 - Psychosocial outcome in a randomized surgical trial for treatment of primary breast can...
17417725 - Breast-conserving surgery for t3/t4 breast cancer: an analysis of 196 patients.
16799355 - Correlates of between-surgeon variation in breast cancer treatments.
549185 - Efficacy of parenteral antibiotics in the treatment of experimentally induced intraabdo...
3280125 - Blood, retinol and zinc riboflavin status in relation to precancerous lesions of the es...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical drug investigation     Volume:  26     ISSN:  1173-2563     ISO Abbreviation:  Clin Drug Investig     Publication Date:  2006  
Date Detail:
Created Date:  2006-12-13     Completed Date:  2007-02-05     Revised Date:  2009-11-03    
Medline Journal Info:
Nlm Unique ID:  9504817     Medline TA:  Clin Drug Investig     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  427-37     Citation Subset:  IM    
Affiliation:
First Department of Anaesthesiology, Toho University School of Medicine, Ohmori-Nishi, Tokyo, Japan. yfujii@med.toho-u.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antiemetics / therapeutic use
Female
Humans
Mastectomy / adverse effects,  methods*
Postoperative Nausea and Vomiting / etiology,  prevention & control*
Practice Guidelines as Topic
Preanesthetic Medication / methods*
Risk Factors
Chemical
Reg. No./Substance:
0/Antiemetics

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Drug-related problems in the community setting: pharmacists' findings and recommendations for people...
Next Document:  Relationship between the frequency of blood pressure self-measurement and blood pressure reduction w...